{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T23:13:07Z","timestamp":1770678787756,"version":"3.49.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.soc.2024.12.003","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T01:51:07Z","timestamp":1737078667000},"page":"145-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular and Genetic Markers of Peritoneal Metastasis"],"prefix":"10.1016","volume":"34","author":[{"given":"Ryan T.","family":"Heslin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary A.","family":"Whitham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex C.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.soc.2024.12.003_bib1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s12094-023-03356-6","article-title":"Neoplastic appendiceal mucinous lesions: a narrative review of the literature from an oncologist's perspective","volume":"26","author":"Ayala-de Miguel","year":"2024","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"10.1016\/j.soc.2024.12.003_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02236899","article-title":"Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies","volume":"41","author":"Connor","year":"1998","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.soc.2024.12.003_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/1066896918784650","article-title":"Unusual histopathological findings in appendectomy specimens: a retrospective analysis of 2047 cases","volume":"27","author":"Unver","year":"2019","journal-title":"Int J Surg Pathol"},{"issue":"5","key":"10.1016\/j.soc.2024.12.003_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1053\/j.semdp.2024.08.005","article-title":"Appendiceal adenocarcinoma: current concepts & challenges","volume":"41","author":"Bell","year":"2024","journal-title":"Semin Diagn Pathol"},{"issue":"13","key":"10.1016\/j.soc.2024.12.003_bib5","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.3390\/cancers15133426","article-title":"Appendiceal mucinous neoplasms: from clinic to pathology and prognosis","volume":"15","author":"Gonzalez Bayon","year":"2023","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.soc.2024.12.003_bib6","doi-asserted-by":"crossref","first-page":"e23270","DOI":"10.1002\/gcc.23270","article-title":"Molecular profiling of low-grade appendiceal mucinous neoplasms (LAMN)","volume":"63","author":"Doll","year":"2024","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"10.1016\/j.soc.2024.12.003_bib7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/bjc.2013.47","article-title":"Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms","volume":"108","author":"Nishikawa","year":"2013","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.soc.2024.12.003_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1245\/s10434-019-07879-7","article-title":"Molecular and genetic markers in appendiceal mucinous tumors: a systematic review","volume":"27","author":"Stein","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.soc.2024.12.003_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/srep00161","article-title":"Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas","volume":"1","author":"Furukawa","year":"2011","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.soc.2024.12.003_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/his.13986","article-title":"Mutation profile of high-grade appendiceal mucinous neoplasm","volume":"76","author":"Liao","year":"2020","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.soc.2024.12.003_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3322\/caac.21601","article-title":"Colorectal cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.soc.2024.12.003_bib12","article-title":"Genomic landscape of appendiceal neoplasms","volume":"2","author":"Ang","year":"2018","journal-title":"JCO Precis Oncol"},{"issue":"4","key":"10.1016\/j.soc.2024.12.003_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1158\/1541-7786.MCR-23-0749","article-title":"Peritoneal microenvironment promotes appendiceal adenocarcinoma growth: a multi-omics approach using patient-derived xenografts","volume":"22","author":"Pattalachinti","year":"2024","journal-title":"Mol Cancer Res"},{"issue":"11","key":"10.1016\/j.soc.2024.12.003_bib14","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/bjs.4375","article-title":"Carcinoid tumour of the appendix","volume":"90","author":"Goede","year":"2003","journal-title":"Br J Surg"},{"issue":"12","key":"10.1016\/j.soc.2024.12.003_bib15","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1158\/1535-7163.MCT-20-0318","article-title":"Molecular characterization of appendiceal goblet cell carcinoid","volume":"19","author":"Arai","year":"2020","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"10.1016\/j.soc.2024.12.003_bib16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/annonc\/mdt591","article-title":"Metastatic pattern in colorectal cancer is strongly influenced by histological subtype","volume":"25","author":"Hugen","year":"2014","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.soc.2024.12.003_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/bjs.1800710311","article-title":"Sites of recurrent tumour after 'curative' colorectal surgery: implications for adjuvant therapy","volume":"71","author":"Gilbert","year":"1984","journal-title":"Br J Surg"},{"issue":"12","key":"10.1016\/j.soc.2024.12.003_bib18","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.soc.2024.12.003_bib19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Quenet","year":"2021","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.soc.2024.12.003_bib20","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.soc.2024.12.003_bib21","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1038\/s41467-022-32198-z","article-title":"Molecular characterization of colorectal cancer related peritoneal metastatic disease","volume":"13","author":"Lenos","year":"2022","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.soc.2024.12.003_bib22","doi-asserted-by":"crossref","first-page":"dju121","DOI":"10.1093\/jnci\/dju121","article-title":"TP53 mutational status and cetuximab benefit in rectal cancer: 5-year results of the EXPERT-C trial","volume":"106","author":"Sclafani","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.soc.2024.12.003_bib23","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1053\/j.gastro.2009.12.065","article-title":"The chromosomal instability pathway in colon cancer","volume":"138","author":"Pino","year":"2010","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.soc.2024.12.003_bib24","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1470-2045(10)70130-3","article-title":"Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis","volume":"11","author":"De Roock","year":"2010","journal-title":"Lancet Oncol"},{"issue":"17","key":"10.1016\/j.soc.2024.12.003_bib25","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","article-title":"K-ras mutations and benefit from cetuximab in advanced colorectal cancer","volume":"359","author":"Karapetis","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.soc.2024.12.003_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.soc.2024.12.003_bib27","doi-asserted-by":"crossref","first-page":"100271","DOI":"10.1016\/j.clinsp.2023.100271","article-title":"Effect of the MiR-99b and MiR-135b on peritoneal carcinomatosis and liver metastasis in colorectal cancer","volume":"78","author":"Aziret","year":"2023","journal-title":"Clinics"},{"issue":"3","key":"10.1016\/j.soc.2024.12.003_bib28","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ijc.28373","article-title":"Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors","volume":"134","author":"Thomassen","year":"2014","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.soc.2024.12.003_bib29","first-page":"224","article-title":"The role of intraperitoneal chemotherapy in the treatment of patients with advanced gastric cancer","volume":"83","author":"Bijelic","year":"2012","journal-title":"Ann Ital Chir"},{"issue":"11","key":"10.1016\/j.soc.2024.12.003_bib30","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3390\/cancers11111662","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer","volume":"11","author":"Gamboa","year":"2019","journal-title":"Cancers"},{"issue":"9742","key":"10.1016\/j.soc.2024.12.003_bib31","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.soc.2024.12.003_bib32","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1245\/s10434-019-07450-4","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer with peritoneal carcinomatosis: multicenter study of Spanish group of peritoneal oncologic surgery (GECOP)","volume":"26","author":"Manzanedo","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2024.12.003_bib33","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S1470-2045(13)70102-5","article-title":"Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial","volume":"14","author":"Lordick","year":"2013","journal-title":"Lancet Oncol"},{"issue":"7517","key":"10.1016\/j.soc.2024.12.003_bib34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Cancer Genome Atlas Research","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.soc.2024.12.003_bib35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nm.3850","article-title":"Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes","volume":"21","author":"Cristescu","year":"2015","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.soc.2024.12.003_bib36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/gutjnl-2018-318070","article-title":"Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.soc.2024.12.003_bib37","doi-asserted-by":"crossref","first-page":"13750","DOI":"10.1038\/srep13750","article-title":"Whole genome and transcriptome sequencing of matched primary and peritoneal metastatic gastric carcinoma","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.soc.2024.12.003_bib38","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s43018-021-00240-6","article-title":"Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities","volume":"2","author":"Tanaka","year":"2021","journal-title":"Nat Cancer"},{"issue":"23","key":"10.1016\/j.soc.2024.12.003_bib39","doi-asserted-by":"crossref","first-page":"34356","DOI":"10.18632\/oncotarget.8879","article-title":"Asparaginyl endopeptidase promotes the invasion and metastasis of gastric cancer through modulating epithelial-to-mesenchymal transition and analysis of their phosphorylation signaling pathways","volume":"7","author":"Cui","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.soc.2024.12.003_bib40","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3390\/ijms19061658","article-title":"The pattern of signatures in gastric cancer prognosis","volume":"19","author":"Machlowska","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.soc.2024.12.003_bib41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11523-012-0239-4","article-title":"High expression of epithelial cellular adhesion molecule in peritoneal metastasis of gastric cancer","volume":"8","author":"Imano","year":"2013","journal-title":"Target Oncol"},{"issue":"23","key":"10.1016\/j.soc.2024.12.003_bib42","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1007\/s00018-008-8281-1","article-title":"The cell-cell adhesion molecule E-cadherin","volume":"65","author":"van Roy","year":"2008","journal-title":"Cell Mol Life Sci"},{"issue":"11\u201312","key":"10.1016\/j.soc.2024.12.003_bib43","doi-asserted-by":"crossref","first-page":"162","DOI":"10.18632\/oncoscience.379","article-title":"E-cadherin and K-ras: implications of a newly developed model of gastric cancer","volume":"4","author":"Till","year":"2017","journal-title":"Oncoscience"},{"issue":"23","key":"10.1016\/j.soc.2024.12.003_bib44","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1002\/cncr.27565","article-title":"Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor\/extracellular signal-regulated kinase\/integrin beta-1-binding protein 1 pathway","volume":"118","author":"Cheng","year":"2012","journal-title":"Cancer"},{"issue":"Suppl 4","key":"10.1016\/j.soc.2024.12.003_bib45","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1245\/s10434-016-5375-0","article-title":"Neurotrophin receptor-interacting melanoma antigen-encoding gene homolog is associated with malignant phenotype of gastric cancer","volume":"23","author":"Kanda","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.soc.2024.12.003_bib46","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1002\/stem.1816","article-title":"Peritoneal milky spots serve as a hypoxic niche and favor gastric cancer stem\/progenitor cell peritoneal dissemination through hypoxia-inducible factor 1alpha","volume":"32","author":"Miao","year":"2014","journal-title":"Stem Cell"},{"issue":"5","key":"10.1016\/j.soc.2024.12.003_bib47","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cellsig.2014.01.025","article-title":"PTEN inhibits the invasion and metastasis of gastric cancer via downregulation of FAK expression","volume":"26","author":"Zhang","year":"2014","journal-title":"Cell Signal"},{"issue":"12","key":"10.1016\/j.soc.2024.12.003_bib48","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1007\/s10620-017-4764-y","article-title":"PTEN gene induces cell invasion and migration via regulating AKT\/GSK-3beta\/beta-catenin signaling pathway in human gastric cancer","volume":"62","author":"Ma","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.soc.2024.12.003_bib49","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1158\/0008-5472.CAN-05-3393","article-title":"Role of the CXCL12\/CXCR4 axis in peritoneal carcinomatosis of gastric cancer","volume":"66","author":"Yasumoto","year":"2006","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.soc.2024.12.003_bib50","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1158\/1078-0432.CCR-10-2475","article-title":"The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer","volume":"17","author":"Yasumoto","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.soc.2024.12.003_bib51","doi-asserted-by":"crossref","first-page":"236","DOI":"10.21037\/atm.2017.03.96","article-title":"Malignant peritoneal mesothelioma: a review","volume":"5","author":"Kim","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.soc.2024.12.003_bib52","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12967-015-0485-1","article-title":"BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma","volume":"13","author":"Alakus","year":"2015","journal-title":"J\u00a0Transl Med"},{"issue":"3","key":"10.1016\/j.soc.2024.12.003_bib53","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/ajcp\/aqad041","article-title":"Characterizing the distribution of alterations in mesothelioma and their correlation to morphology","volume":"160","author":"Chen-Yost","year":"2023","journal-title":"Am J Clin Pathol"},{"issue":"16","key":"10.1016\/j.soc.2024.12.003_bib54","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1158\/0008-5472.CAN-14-1328","article-title":"Germline mutation of BAP1 accelerates development of asbestos-induced malignant mesothelioma","volume":"74","author":"Xu","year":"2014","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.soc.2024.12.003_bib55","doi-asserted-by":"crossref","first-page":"103644","DOI":"10.1016\/j.esmoop.2024.103644","article-title":"Update on gene fusions and the emerging clinicopathological landscape of peritoneal and pleural mesotheliomas and other neoplasms","volume":"9","author":"Benzerdjeb","year":"2024","journal-title":"ESMO Open"},{"issue":"3","key":"10.1016\/j.soc.2024.12.003_bib56","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.soc.2024.12.003_bib57","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jso.21288","article-title":"Intra-abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer","volume":"99","author":"Sehouli","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"issue":"7","key":"10.1016\/j.soc.2024.12.003_bib58","doi-asserted-by":"crossref","first-page":"C444","DOI":"10.1152\/ajpcell.00188.2015","article-title":"Cellular and molecular processes in ovarian cancer metastasis. A review in the theme: cell and molecular processes in cancer metastasis","volume":"309","author":"Yeung","year":"2015","journal-title":"Am J Physiol Cell Physiol"},{"issue":"11","key":"10.1016\/j.soc.2024.12.003_bib59","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1136\/ijgc-2020-001556","article-title":"Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes","volume":"30","author":"Pietragalla","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"12","key":"10.1016\/j.soc.2024.12.003_bib60","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/humu.20599","article-title":"Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer","volume":"28","author":"Ramus","year":"2007","journal-title":"Hum Mutat"},{"issue":"7353","key":"10.1016\/j.soc.2024.12.003_bib61","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research","year":"2011","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.soc.2024.12.003_bib62","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1158\/0008-5472.CAN-08-4151","article-title":"Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination","volume":"69","author":"Moss","year":"2009","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.soc.2024.12.003_bib63","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/0008-5472.CAN-07-5167","article-title":"Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target","volume":"68","author":"Sawada","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.soc.2024.12.003_bib64","doi-asserted-by":"crossref","first-page":"e59442","DOI":"10.7554\/eLife.59442","article-title":"Collagen-rich omentum is a premetastatic niche for integrin alpha2-mediated peritoneal metastasis","volume":"9","author":"Huang","year":"2020","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.soc.2024.12.003_bib65","first-page":"101","article-title":"The role of MMP-14 in ovarian cancer: a systematic review","volume":"14","author":"Vos","year":"2021","journal-title":"J\u00a0Ovarian Res"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320724000899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320724000899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T14:46:33Z","timestamp":1750862793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320724000899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1055320724000899"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2024.12.003","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular and Genetic Markers of Peritoneal Metastasis","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2024.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}